LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

Search

Champions Oncology Inc

Geschlossen

BrancheGesundheitswesen

6.26 1.29

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

5.45

Max

6.41

Schlüsselkennzahlen

By Trading Economics

Einkommen

-514K

-278K

Verkäufe

1.5M

17M

KGV

Branchendurchschnitt

35.118

50.958

EPS

-0.02

Gewinnspanne

-1.679

Angestellte

213

EBITDA

-508K

104K

Dividenden

By Acuity

Nächstes Ergebnis

22. Juli 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

3.9M

87M

Vorheriger Eröffnungskurs

4.97

Vorheriger Schlusskurs

6.26

Nachrichtenstimmung

By Acuity

100%

0%

323 / 342 Ranking in Healthcare

Champions Oncology Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Über Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
help-icon Live chat